Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL 14736, Pliva) Current Pharmaceutical Design Comprehensive review of BPC 157 clinical development for inflammatory bowel disease including ulcerative colitis trials, demonstrating mucosal healing and anti-inflammatory effects across multiple organ systems
This fluorescence characteristic can be used for qualitative and quantitative analysis of peptides
Aging & Longevity Research Applications Due to its role in NAD metabolism and methylation control, 5-Amino-1MQ is frequently studied in the context of cellular aging and longevity-associated biological processes
BPC-157 is a 15-amino-acid pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and a target molecular weight of approximately 1419.5 g/mol
US$ 20.88
US$ 22.34
US$ 23.72
US$ 26.16
US$ 20.62
US$ 28.66
US$ 28.63
